Please assess the completion status of the following clinical trial:

Trial Title: OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, \>=18 years of age;~* locally advanced or metastatic colorectal cancer;~* no previous treatment with chemotherapy for metastatic disease;~* at least one measurable lesion.~Exclusion Criteria:~* radiotherapy to any site within 4 weeks before study;~* untreated brain metastases or primary brain tumors;~* clinically significant cardiovascular disease;~* chronic daily treatment with high dose aspirin (\>325 mg/day);~* other co-existing malignancies or malignancies diagnosed within last 5 years.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).